Literature DB >> 15314124

Testosterone deficiency and apathy in Parkinson's disease: a pilot study.

R E Ready1, J Friedman, J Grace, H Fernandez.   

Abstract

BACKGROUND: Low testosterone in men with Parkinson's disease may be associated with non-motor symptoms of the disease, such as apathy.
OBJECTIVE: To determine the association between free serum testosterone level and apathy in elderly men with Parkinson's disease.
METHODS: Consecutive non-demented patients (n = 49) and knowledgeable informants (n = 40) participated in the study. Patients and informants reported on apathy using the Frontal Systems Behavior Scale and two visual analogue scales. Patients also provided self reported symptoms of depression on the Beck depression inventory-II. Blood samples were drawn at the time of assessment to determine testosterone levels.
RESULTS: A low total testosterone concentration was found in 46.9% of the patients, defined as < or = 325 ng/dl. Free testosterone was significantly correlated with both patient reported and informant reported apathy, independent of disease severity.
CONCLUSIONS: Apathy is common in Parkinson's disease and is inversely correlated with free testosterone. Testosterone replacement therapy could be considered as a potential treatment for apathy in some men with Parkinson's disease. More research is needed to replicate these findings and to investigate the response to treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15314124      PMCID: PMC1739210          DOI: 10.1136/jnnp.2003.032284

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Sexual wellbeing in Parkinson's disease.

Authors:  S F Farmer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

3.  Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta.

Authors:  Rebecca L Cunningham; Andrea Giuffrida; James L Roberts
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

4.  Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

Authors:  Kenn Freddy Pedersen; Guido Alves; Kolbjørn Brønnick; Dag Aarsland; Ole-Bjørn Tysnes; Jan Petter Larsen
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

5.  Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.

Authors:  Dennis J Zgaljardic; Joan C Borod; Nancy S Foldi; Mary Rocco; Paul J Mattis; Mark F Gordon; Andrew S Feigin; David Eidelberg
Journal:  Cogn Behav Neurol       Date:  2007-09       Impact factor: 1.600

6.  Primary progressive multiple sclerosis takes centre stage.

Authors:  P M Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

7.  Apathy in Parkinson's disease is related to executive function, gender and age but not to depression.

Authors:  Antonia Meyer; Ronan Zimmermann; Ute Gschwandtner; Florian Hatz; Habib Bousleiman; Nadine Schwarz; Peter Fuhr
Journal:  Front Aging Neurosci       Date:  2015-01-15       Impact factor: 5.750

8.  Integrated molecular landscape of Parkinson's disease.

Authors:  J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser
Journal:  NPJ Parkinsons Dis       Date:  2017-04-10

9.  Testosterone Upregulates the Expression of Mitochondrial ND1 and ND4 and Alleviates the Oxidative Damage to the Nigrostriatal Dopaminergic System in Orchiectomized Rats.

Authors:  Wensheng Yan; Yunxiao Kang; Xiaoming Ji; Shuangcheng Li; Yingkun Li; Guoliang Zhang; Huixian Cui; Geming Shi
Journal:  Oxid Med Cell Longev       Date:  2017-08-24       Impact factor: 6.543

Review 10.  The Role of Sex Therapy in the Management of Patients with Parkinson's Disease.

Authors:  Gila Bronner; Amos D Korczyn
Journal:  Mov Disord Clin Pract       Date:  2017-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.